U-73122 U-73122 is a phospholipase C,phospholipase A2, and 5-LO inhibitor.

U-73122 (CAS 112648-68-7)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 109ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
U-73122 is rated 5.0 out of 5 by 2.
5
2
4
0
3
0
2
0
1
0
Alternative Namen: 1-(6-((17β-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
Anwendungen U-73122 is a phospholipase C,phospholipase A2, and 5-LO inhibitor
CAS Nummer: 112648-68-7
Reinheit: ≥98%
Molekulargewicht: 464.64
Summenformel: C29H40N2O3
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
* Schauen Sie auf das Analysezertifikat (CoA), um die genauen Daten (inkl. Wassergehalt) Ihrer Produktionscharge (Lot) zu sehen.

U-73122 is an inhibitor of phospholipase C, phospholipase A2, and 5-LO (5-lipoxygenase). In neutrophils and human platelets, U-73122 inhibits agonist-induced phospholipase C (IC50=1.0-2.1 µM) activation. This compound affects the phospholipases by inhibiting the hydrolysis of PPI (phosphatidylinositol) to IP3 (inositol triphosphate), which in turn leads to a drop in cytosolic Ca2+. In SK-N-SH neuroblastoma cells, U-73122 inhibits agonist-induced down-regulation of muscarinic receptors. In addition, it is a useful tool to investigate receptor-mediated PI turnover in signal transduction. U-73122 is a potent inhibitor of human neutrophil adhesion to biological surfaces (IC50 = 50 nM) as well as adhesion-dependent granule exocytosis and oxidative burst. U-73343 (sc-201422) is useful as a negative control for investigations of U-73122 phospholipase C antagonism and its cellular consequences.


Literaturhinweise

1. Smith, R.J., et al. 1990. J. Pharmacol. Exp. Ther. 253: 688-697. PMID: 2338654
2. Bleasdale, J.E., et al. 1990. J. Pharmacol. Exp. Ther. 255 756-768. PMID: 2147038
3. Thompson A.K., et al. 1991. J. Biol. Chem. 266: 23856-23862. PMID: 1660886
4. Yule, D.I., et al. 1992. J. Biol. Chem. 267: 13830-13835. PMID: 1629184
5. Smith, R.J., et al. 1996. J. Pharmacol. Exp. Ther. 278: 320-329. PMID: 8764366

Gebrauch :
U-73122 is only sparingly soluble in aqueous media. Because of this U-73122 can only be delivered to the cell by forming a complex with serum proteins or by dissolving it with an organic solvent.
Preparation of Working Solutions:
1. Dissolve U-73122 in Dichloromethane (sc-239703) or Chloroform (sc-239527).
2. Aliquot amount needed for a single experiemnt into suitable vials.
3. Evaporate the methylene chloride or chloroform using nitrogen.
4. The result is a film of U-73122 that can be dissolved in DMSO (5mM), ethanol (2mM in 100%) or an aqueous medium that contains serum or serum albumin (1-10 mg/mL), which forms a complex with U-73122, thus eliminating the need to use an organic solvent to deliver the compound to the cells.
Useful Range of Concentrations:
Useful concentrations of U-73122 range between 0.1 and 10 µM. Several factors affect the necessary concentration including: cell density, cell type, medium concentration and the particular variable that is being measured.
Aggregatzustand :
Solid
Löslichkeit :
Soluble in anhydrous DMSO (1 mg/ml), DMF, PBS pH7.2, anhydrous Chloroform (3 mg/ml), anhydrous Ethanol (500 µg/ml), dichloromethane, and aqueous solutions (sparingly). Insoluble in water.
LAGERUNG: :
Store at room temperature
Schmelztemperatur :
121-122° C
Sidepunkt :
617.14° C at 760 mmHg (Predicted)
Dichte :
1.17 g/cm3 (Predicted)
Brechungsindex :
n20D 1.59 (Predicted)
IC50 :
Recombinant enzyme: IC50 = 30 nM; Neutrophil Elastase: IC50 = 50 nM (human); Parathyroid hormone-induced Ca2+ transients: IC50 = 0.5 µM; Platelet aggregation induced by collagen: IC50 = 0.6 µM; ET-1 hormone-induced Ca2+ transients: IC50 = 0.8 µM; PMNL homogenates: IC50 = 2.4 µM; Platelet aggregation induced by thrombin : IC50 = 5 µM; HIV-1 integrase: IC50 = 7 µM
pK Werte :
pKb: 10.69 (Predicted)
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
PubChem CID :
5631
SMILES :
CC12CCC3C(C1CCC2NCCCCCCN4C(=O)C=CC4=O)CCC5=C3C=CC(=C5)OC

SDS (MSDS) herunterladen

Analysenzertifikat

Um PDF-Dokumente zu Drucken oder zu Bearbeiten
benötigen Sie Adobe Acrobat Reader

U-73122 (CAS 112648-68-7)  Publikationen

Lesen Sie wie andere Anwender U-73122 (CAS 112648-68-7) eingesetzt haben. Klicken Sie auf den jeweiligen Eintrag um den entsprechenden PubMed-Abstract abzurufen .

Produktreferenz 1 bis 10 von 43 insgesamt

PMID: # 30206934  Tantilertanant, Y.|Niyompanich, J.|Everts, V.|Supaphol, P.|Pavasant, P.|Sanchavanakit, N.| et al. 2019. J. Cell. Physiol. 234: 4528-4539.

PMID: # 30103900  Sharapova, TN.|Romanova, EA.|Sashchenko, LP.|Yashin, DV.| et al. 2018. Biochimie. 152: 174-180.

PMID: # 29251630  Leung, CS.|Yeung, TL.|Yip, KP.|Wong, KK.|Ho, SY.|Mangala, LS.|Sood, AK.|Lopez-Berestein, G.|Sheng, J.|Wong, ST.|Birrer, MJ.|Mok, SC.| et al. 2018. J. Clin. Invest. 128: 589-606.

PMID: # 27189756  Do Van, B.|Gouel, F.|Jonneaux, A.|Timmerman, K.|Gelé, P.|Pétrault, M.|Bastide, M.|Laloux, C.|Moreau, C.|Bordet, R.|Devos, D.|Devedjian, JC.| et al. 2016. Neurobiol. Dis. 94: 169-78.

PMID: # 27127172  Kamranvar, SA. et al. 2016. Oncotarget. 7: 30820-30.

PMID: # 27746193  Gao, J.|Bai, T.|Ren, L.|Ding, Y.|Zhong, X.|Wang, H.|Guo, Y.|Li, J.|Liu, Y.|Zhang, Y.| et al. 2016. Peptides. 86: 72-79.

PMID: # 26925647  Akekawatchai, C. et al. 2016. Asian Pac. J. Cancer Prev. 17: 581-90.

PMID: # 27733612  Bellocchio, L. et al. 2016. J. Neurosci. 36: 10611-10624.

PMID: # 26673139  Galindo-Villegas, J. et al. 2016. J. Immunol. 196: 738-49.

PMID: # 26185418  Khan, N. et al. 2015. Drug design, development and therapy. 9: 3497-506.

Produktreferenz 1 bis 10 von 43 insgesamt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 150ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. ist weltweit führend in der Entwicklung von Produkten für den biomedizinischen Forschungsmarkt. Rufen Sie uns an, gebührenfrei unter 00800 4573 8000. .
Copyright © 2007-2020, Santa Cruz Biotechnology, Inc. Alle Rechte vorbehalten. "Santa Cruz Biotechnology", das Santa Cruz Biotechnology, Inc. Logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", das San Juan Ranch Logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz" und "EZ Touch" sind eingetragene Warenzeichen der Santa Cruz Biotechnology, Inc. Alle genannte Warenzeichen sind Eigentum der jeweiligen Inhaber. Alle Rechte vorbehalten.